Correction: CYP2C9 Genotype vs. Metabolic Phenotype for Individual Drug Dosing—A Correlation Analysis Using Flurbiprofen as Probe Drug

Detalles Bibliográficos
Autores principales: Vogl, Silvia, Lutz, Roman W., Schönfelder, Gilbert, Lutz, Werner K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4395445/
https://www.ncbi.nlm.nih.gov/pubmed/25875957
http://dx.doi.org/10.1371/journal.pone.0126329
_version_ 1782366451907166208
author Vogl, Silvia
Lutz, Roman W.
Schönfelder, Gilbert
Lutz, Werner K.
author_facet Vogl, Silvia
Lutz, Roman W.
Schönfelder, Gilbert
Lutz, Werner K.
author_sort Vogl, Silvia
collection PubMed
description
format Online
Article
Text
id pubmed-4395445
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-43954452015-04-21 Correction: CYP2C9 Genotype vs. Metabolic Phenotype for Individual Drug Dosing—A Correlation Analysis Using Flurbiprofen as Probe Drug Vogl, Silvia Lutz, Roman W. Schönfelder, Gilbert Lutz, Werner K. PLoS One Correction Public Library of Science 2015-04-13 /pmc/articles/PMC4395445/ /pubmed/25875957 http://dx.doi.org/10.1371/journal.pone.0126329 Text en © 2015 Vogl et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Correction
Vogl, Silvia
Lutz, Roman W.
Schönfelder, Gilbert
Lutz, Werner K.
Correction: CYP2C9 Genotype vs. Metabolic Phenotype for Individual Drug Dosing—A Correlation Analysis Using Flurbiprofen as Probe Drug
title Correction: CYP2C9 Genotype vs. Metabolic Phenotype for Individual Drug Dosing—A Correlation Analysis Using Flurbiprofen as Probe Drug
title_full Correction: CYP2C9 Genotype vs. Metabolic Phenotype for Individual Drug Dosing—A Correlation Analysis Using Flurbiprofen as Probe Drug
title_fullStr Correction: CYP2C9 Genotype vs. Metabolic Phenotype for Individual Drug Dosing—A Correlation Analysis Using Flurbiprofen as Probe Drug
title_full_unstemmed Correction: CYP2C9 Genotype vs. Metabolic Phenotype for Individual Drug Dosing—A Correlation Analysis Using Flurbiprofen as Probe Drug
title_short Correction: CYP2C9 Genotype vs. Metabolic Phenotype for Individual Drug Dosing—A Correlation Analysis Using Flurbiprofen as Probe Drug
title_sort correction: cyp2c9 genotype vs. metabolic phenotype for individual drug dosing—a correlation analysis using flurbiprofen as probe drug
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4395445/
https://www.ncbi.nlm.nih.gov/pubmed/25875957
http://dx.doi.org/10.1371/journal.pone.0126329
work_keys_str_mv AT voglsilvia correctioncyp2c9genotypevsmetabolicphenotypeforindividualdrugdosingacorrelationanalysisusingflurbiprofenasprobedrug
AT lutzromanw correctioncyp2c9genotypevsmetabolicphenotypeforindividualdrugdosingacorrelationanalysisusingflurbiprofenasprobedrug
AT schonfeldergilbert correctioncyp2c9genotypevsmetabolicphenotypeforindividualdrugdosingacorrelationanalysisusingflurbiprofenasprobedrug
AT lutzwernerk correctioncyp2c9genotypevsmetabolicphenotypeforindividualdrugdosingacorrelationanalysisusingflurbiprofenasprobedrug

Ejemplares similares